JAK inhibition in the type I interferonopathies.

Crow, Yanick J; Neven, Bénédicte; Frémond, Marie-Louise

Crow, Yanick J; Neven, Bénédicte; Frémond, Marie-Louise.

Afiliação

Crow YJ; MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom; University of Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, Paris, France. Electronic address: yanickcrow@mac.com.
Neven B; University of Paris, Paris, France; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP Centre Université de Paris, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Imagine Institute, Paris, France.
Frémond ML; University of Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, Paris, France; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP Centre Université de Paris, Paris, France.

J Allergy Clin Immunol ; 148(4): 991-993, 2021 10.

Article em En | MEDLINE | ID: mdl-34375617

Assuntos

Doenças Autoimunes/tratamento farmacológico; Doenças Hereditárias Autoinflamatórias/tratamento farmacológico; Interferon Tipo I; Inibidores de Janus Quinases/uso terapêutico; Humanos

Palavras-chave

JAK inhibition; Type I interferonopathies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Interferon Tipo I / Doenças Hereditárias Autoinflamatórias / Inibidores de Janus Quinases Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google